Fortrea Apresenta Solução Abrangente para Aprimorar a Diversidade e Inclusão na Pesquisa Clínica
31 mai 2024 13h24 HE
|
Fortrea Holdings Inc
DURHAM, N.C., May 31, 2024 (GLOBE NEWSWIRE) -- A Fortrea (Nasdaq: FTRE) (a “Empresa”), uma organização líder global de pesquisa por contrato (CRO), anunciou hoje o lançamento da sua solução...
Fortrea, 임상연구에서 다양성과 포용성 개선을 위해 종합 솔루션 출시
31 mai 2024 13h24 HE
|
Fortrea Holdings Inc
더럼, 노스캐롤라이나, June 01, 2024 (GLOBE NEWSWIRE) -- 글로벌 임상시험 수탁기관(CRO)인 Fortrea (나스닥명: FTRE)가 임상시험 참가자의 다양성 및 포용성(D&I) 개선을 위한 포괄적이고 통합적인 솔루션을 발표했다. Fortrea의 D&I 솔루션은 환자들의 임상시험 참가 기회를 확대하고 아울러...
Fortrea 推出改善临床研究中多样性和入选的综合解决方案
31 mai 2024 13h24 HE
|
Fortrea Holdings Inc
北卡罗来纳州，达勒姆, June 01, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) （以下简称“公司”）, 一家全球领先的合同研究组织 (CRO) ，今天宣布推出全面的综合解决方案，以改善临床试验参与者的多样性和入选 (D&I)。Fortrea 的 D&I 解决方案旨在增加患者参与临床试验的机会，并满足美国食品药品监督管理局...
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
30 mai 2024 07h00 HE
|
Fortrea Holdings Inc
DURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced its comprehensive and integrated...
Fortrea Appoints Machelle Sanders to Board of Directors
16 mai 2024 16h05 HE
|
Fortrea Holdings Inc
DURHAM, N.C., May 16, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced the appointment of Machelle Sanders to...
Fortrea Reports First Quarter 2024 Results
13 mai 2024 06h30 HE
|
Fortrea Holdings Inc
For the three months ended March 31, 2024, from continuing operations: Revenues of $662.1 millionGAAP net loss of $81.6 millionAdjusted EBITDA of $29.5 millionGAAP and adjusted diluted earnings...
Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference Call
06 mai 2024 08h22 HE
|
Fortrea Holdings Inc
DURHAM, N.C., May 06, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced an updated issuance date for the...
Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
11 avr. 2024 07h00 HE
|
Fortrea Holdings Inc
DURHAM, N.C., April 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter...
Fortrea Assina Contrato Definitivo de Transferência das Unidades Endpoint Clinical e Patient Access para a Arsenal Capital Partners
12 mars 2024 12h18 HE
|
Fortrea Holdings Inc
A proposta da transferência das unidades Endpoint Clinical e Fortrea Patient Access agiliza ainda mais o foco estratégico da Fortrea como uma organização de pesquisa sob contrato Ela cria as melhores...
Fortrea Menandatangani Perjanjian Definitif untuk Mendivestasi Bisnis Endpoint Clinical dan Patient Access ke Arsenal Capital Partners
12 mars 2024 12h18 HE
|
Fortrea Holdings Inc
Rencana divestasi bisnis Endpoint Clinical dan Fortrea Patient Access makin merampingkan fokus strategis Fortrea sebagai sebagai organisasi riset kontrak murni. Menciptakan solusi Randomisasi dan...